BYDUREON BCISE
BYDUREON BCISE
Discontinued
DIN Number
02483203
Drug Class
Human
Market Date
N/A
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02483203
AIG Number0152872002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BJ01 EXENATIDE
Product Specifications
Dosage FormSuspension (Extended-Release)
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
EXENATIDEActive
Strength: 2 MG / DOSE
Monograph: EXENATIDE